VALEANT PHARMACEUTICALS's ticker is and the CUSIP is 91831AAC5. A total of 1 filers reported holding VALEANT PHARMACEUTICALS in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $12,421,000 | +0.3% | 14,380,000 | -6.5% | 0.18% | -6.2% |
| Q2 2016 | $12,381,000 | +54.4% | 15,380,000 | +48.2% | 0.19% | +57.4% |
| Q1 2016 | $8,019,000 | -27.5% | 10,380,000 | -15.3% | 0.12% | -28.2% |
| Q4 2015 | $11,056,000 | +189.4% | 12,250,000 | +206.2% | 0.17% | +193.1% |
| Q3 2015 | $3,820,000 | +85.2% | 4,000,000 | +100.0% | 0.06% | +93.3% |
| Q2 2015 | $2,063,000 | – | 2,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT CAPITAL MANAGEMENT /DE/ | 10,380,000 | $8,019,000 | 0.12% |